Genome International India Private Limited

Genome International India Private Limited - information technology in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U73100TN2004PTC053684 Incorporated 09 July 2004 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company information technology
Data last updated
Revenue · FY 2024
₹3.08 Cr
▼ 9% YoY
Net loss · FY 2024
₹11.72 Lakh
Net margin -3.8%
EBITDA · FY 2024
-₹4.51 Lakh
EBITDA margin -1.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.02 Lakh
Issued & subscribed
Company age
22 yrs
Est. 2004
Employees · EPFO
30
Provident fund records
Directors on board
2
As per MCA filings

About Genome International India Private Limited

Data last updated:

Genome International India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the application development and software solutions segment of the technology and IT services sector. It was incorporated on 09 July 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U73100TN2004PTC053684. Its GSTIN is 33AAECG4502G2Z3 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.02 Lakh. It was formerly known as Genome International Private Limited. It is led by directors Periannan Senapathy and Abarajeetha Rajendran.

Its last annual general meeting (AGM) was held on 29 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.08 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹11.72 Lakh (net margin -3.8%) and EBITDA of -₹4.51 Lakh (EBITDA margin -1.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.

The company has about 30 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Genome Life Sciences. Court records list 3 cases involving the company, including 3 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomels.com.

Company details

CIN U73100TN2004PTC053684
Registration Number 053684
Incorporation Date 09 July 2004
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 December 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Name history

Genome International India has undergone 3 name changes throughout its history. The company was previously known as Genome International Private Limited, Genome International India Private Limited, and Genome Life Sciences Private Limited. The current legal name is Genome International India Private Limited.

Company NameStatus
Genome International India Private LimitedCurrent
Genome International Private LimitedPrevious
Genome Life Sciences Private LimitedPrevious

CIN history

Genome International India has one previous CIN (Corporate Identification Number): U72200TN2004PTC053684. The current CIN is U73100TN2004PTC053684, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100TN2004PTC053684Current
U72200TN2004PTC053684Previous

Contact details

Genome International India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is genomels.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096
  • Industry
    Information Technology, Application Development & Software Solutions

To see the full contact details of Genome International India Private Limited, buy the company report.

Comprehensive company report
Genome International India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Genome International India operates one associated brand: Genome Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Delivers comprehensive services for next-generation sequencing and big data analysis in life sciences.genomels.com

Business activity

The main business activity of Genome International India is information and communication. In detail, this covers publishing of computer operating systems, system software, application software, games, etc..

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
JInformation and communicationJ2Publishing of computer operating systems, system software, application software, games, etc.

To see the full business activity and turnover split of Genome International India Private Limited, buy the company report.

Financials of Genome International India Private Limited

FY 2025 filings available

Genome International India Private Limited reported revenue of ₹3.08 Cr (down 9% YoY) for FY 2024.

Revenue · FY 2024
₹3.08 Cr ▼ 9%
Net loss · FY 2024
₹11.72 Lakh margin -3.8%
EBITDA · FY 2024
-₹4.51 Lakh margin -1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 1%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 200%
3 years · compounded
▼ 2%
5 years · compounded
▼ 26%

Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 200% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.51 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.72 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-1.5%
Net Profit Margin-3.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Genome International India Private Limited, buy the company report.

Board of directors of Genome International India Private Limited

Genome International India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Periannan SenapathyDirector09 Jul 200422 Years 3 MonthsCurrent
Abarajeetha RajendranDirector09 Aug 20233 Years 2 MonthsCurrent

Auditor

Genome International India Private Limited is audited by S BALA & CO for the financial year 2018.

Auditor firmFinancial yearFirm registration number
S BALA & COFY 2018013958S

Shareholding

The shareholding of Genome International India Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Genome International India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Genome International India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Genome International India Private Limited has a workforce of 30 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.

Employee count
30
Active EPFO establishments
1

GST

Genome International India has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
33AAECG4502G2Z3Tamil NaduActive06 Jun 2018

To see the full GST registrations and return filing status of Genome International India Private Limited, buy the company report.

Recent activity

Genome International India Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Abarajeetha Rajendran ceased to be Additional Director on 22 Aug 2023.

AGM
Genome International India Private Limited last Annual general meeting of members was held on 29 Dec 2025 as per latest MCA records.
Filing
Genome International India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Abarajeetha Rajendran ceased to be Additional Director.
Ceased
Nathambal ceased to be Director.
Appointed
Abarajeetha Rajendran was appointed as Director.
Ceased
Roopamala Senapathy ceased to be Director.
Ceased
Kalpana Mandradiar ceased to be Director.
Appointed
Nathambal was appointed as Director.
Appointed
Periannan Senapathy was appointed as Director.
Incorporation
09 Jul 2004
Genome International India Private Limited was registered on 09 Jul 2004 with Roc Chennai & aged 22 years 3 months as per MCA records.

Frequently asked questions

Genome International India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in application development and software solutions, within the information technology industry. It was incorporated on 09 July 2004 (22+ years old) and is registered under CIN U73100TN2004PTC053684.

Genome International India has 2 current directors:

The latest financial statements of Genome International India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 December 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Genome International India is 33AAECG4502G2Z3, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Genome International India is U73100TN2004PTC053684. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Genome International India has 3 court cases on record: 3 filed against it.

Genome International India was incorporated on 09 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.

Abarajeetha Rajendran ceased to be Additional Director on 22 Aug 2023. Nathambal ceased to be Director on 11 Aug 2023. Abarajeetha Rajendran was appointed as Director on 09 Aug 2023. Genome International India has 7 board changes on record in total.

Genome International India can be reached through the website genomels.com. Its registered office is in Chennai, Tamil Nadu, India.

The registered office of Genome International India is at 383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096.